[Class : 5] Medicinal And Pharmaceutical Preparations.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Medicinal And Pharmaceutical Preparations.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Medicinal And Pharmaceutical Preparations.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +1 more Brands for Anchor Medicare Private Limited.
Documents
Form MGT-7-11112019_signed
List of share holders, debenture holders;-06112019
Form DIR-12-21102019_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-16102019
Directors report as per section 134(3)-16102019
Form AOC-4-16102019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-14012019
Evidence of cessation;-14012019
Form DIR-12-14012019_signed
Notice of resignation;-14012019
Optional Attachment-(1)-14012019
Optional Attachment-(2)-14012019
List of share holders, debenture holders;-01082018
Form MGT-7-01082018_signed
Form DIR-12-24072018_signed
Form AOC-4-24072018_signed
Directors report as per section 134(3)-23072018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-23072018
Form DIR-12-01032018_signed
Optional Attachment-(1)-28022018
Notice of resignation;-28022018
Interest in other entities;-28022018
Evidence of cessation;-28022018
Declaration of the appointee director, Managing director, in Form No. DIR-2;-28022018
Declaration by first director-28022018
List of share holders, debenture holders;-17112017
Form MGT-7-17112017_signed
Form AOC-4-30102017_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-27102017